The Drug Metabolism market within the context of Biotechnology is a rapidly growing sector, with a focus on the development of new drugs and treatments. It involves the study of how drugs are broken down and metabolized in the body, and how this affects their efficacy and safety. This market is driven by the need for more effective and safer drugs, as well as the increasing demand for personalized medicine. Companies in this market are developing new technologies to improve drug metabolism, such as artificial intelligence and machine learning. They are also exploring new ways to identify and target drug metabolism pathways, as well as developing new drug delivery systems. Some companies in the Drug Metabolism market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
